PMID: 7025996Sep 1, 1981Paper

Control of gastric acidity with cimetidine given as premedication before general anesthesia: efficacy and tolerance

Canadian Anaesthetists' Society Journal
D RicheJ M Pacouret

Abstract

Cimetidine 400 mg was administered intramuscularly 60 minutes before the beginning of general anaesthesia. The double blind experiment was conducted on 84 patients divided in two groups: cimetidine and control. There was no difference in gastric fluid volume between the two groups during general anaesthesia, but acid secretion decreased significantly in the cimetidine group. Values of pH lower than 2.5 were observed in 33.3 per cent at induction and 34 per cent at recovery in the control group against 14.6 per cent and 0 per cent in the cimetidine group. Clinical tolerance to cimetidine was studied in 100 patients during operation. Cimetidine did not alter pharmacological action of usual anaesthetics. There were no significant changes in cardiovascular and electrocardiographic data.

References

Jun 1, 1977·British Journal of Anaesthesia·J B Hester, M L Heath
May 1, 1978·Anesthesia and Analgesia·A H GieseckeF T Kallus
Oct 1, 1978·Anaesthesia·R P HusemeyerT Rajasekaran
Dec 1, 1978·British Journal of Anaesthesia·P J KeatingD W Watson
May 1, 1979·Anesthesia and Analgesia·D W CoombsT Colton
Jul 1, 1979·Anesthesia and Analgesia·K Maliniak, A H Vakil
Sep 13, 1979·The New England Journal of Medicine·T R Engel, J C Luck
Nov 1, 1979·Anesthesiology·N L PaceT Mashimo
Oct 1, 1977·Lancet·W GraveJ J Rutten
Dec 10, 1977·Lancet·P RedingP Barbier
Apr 15, 1978·Lancet·D B Jefferys, J A Vale
Apr 15, 1978·Lancet·W A Mahon, M Kolton
Aug 18, 1979·Lancet·M J SerlinJ M Willoughby
May 1, 1975·British Journal of Anaesthesia·G Taylor
Nov 2, 1978·The New England Journal of Medicine·W Finkelstein, K J Isselbacher
Mar 1, 1979·British Journal of Anaesthesia·G A Heaney, H D Jones
Nov 1, 1979·Anesthesiology·C P GibbsE J Kuck
Sep 29, 1979·British Medical Journal·J CohenD M Krikler
Dec 1, 1978·Annals of Internal Medicine·M LigumskyD Rachmilewitz
Oct 1, 1977·Agents and Actions·G MauraP S Timiras
Jan 1, 1970·British Journal of Anaesthesia·J S Crawford
May 1, 1980·The New England Journal of Medicine·U Klotz, I Reimann
Jul 1, 1956·Anaesthesia·G EDWARDSW D WYLIE
Mar 1, 1962·Anesthesiology·W K BANNISTER, A J SATTILARO
Feb 28, 1962·Annals of the New York Academy of Sciences·R YOUNG, D C SUN
Apr 1, 1963·British Journal of Anaesthesia·B S CLIFTON, W I HOTTEN

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.